3 days popular7 days popular1 month popular3 months popular

Combination therapy may offer better outcomes for patients with retinoblastoma

Researchers at The Saban Research Institute of Children’s Hospital Los Angeles (CHLA) have demonstrated that targeting survivin — a protein that inhibits apoptosis or cell death — enhances the effectiveness of chemotherapy in cells and mouse models of retinoblastoma (Rb), the most common malignant tumor of the eye in children.

Retinoblastoma Tumor Cells
This is a picture of retinoblastoma tumor cells.
Credit: Courtesy of Children’s Hospital Los Angeles